CN Patent

CN108024996A — 布鲁顿氏酪氨酸激酶抑制剂组合和其用途

Assigned to Pharmacyclics LLC · Expires 2018-05-11 · 8y expired

What this patent protects

公开了用于治疗实体肿瘤的组合物、方法和试剂盒，包含向有需要的个体共给予BTK抑制剂和mTOR抑制剂；紫杉烷或EGFR抑制剂。

USPTO Abstract

公开了用于治疗实体肿瘤的组合物、方法和试剂盒，包含向有需要的个体共给予BTK抑制剂和mTOR抑制剂；紫杉烷或EGFR抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN108024996A
Jurisdiction
CN
Classification
—
Expires
2018-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacyclics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.